NVDA NVIDIA Corporation

NVIDIA Announces Financial Results for Fourth Quarter and Fiscal 2020

NVIDIA Announces Financial Results for Fourth Quarter and Fiscal 2020

SANTA CLARA, Calif., Feb. 13, 2020 (GLOBE NEWSWIRE) -- NVIDIA (NASDAQ: NVDA) today reported revenue for the fourth quarter ended Jan. 26, 2020, of $3.11 billion, up 41 percent from $2.21 billion a year earlier, and up 3 percent from $3.01 billion in the previous quarter.

GAAP earnings per diluted share for the quarter were $1.53, up 66 percent from $0.92 a year ago, and up 6 percent from $1.45 in the previous quarter. Non-GAAP earnings per diluted share were $1.89, up 136 percent from $0.80 a year earlier, and up 6 percent from $1.78 in the previous quarter.

For fiscal 2020, revenue was $10.92 billion, down 7 percent from $11.72 billion a year earlier. GAAP earnings per diluted share were $4.52, down 32 percent from $6.63 a year earlier. Non-GAAP earnings per diluted share were $5.79, down 13 percent from $6.64 a year earlier.

“Adoption of NVIDIA accelerated computing drove excellent results, with record data center revenue,” said Jensen Huang, founder and CEO of NVIDIA. “Our initiatives are achieving great success.

“NVIDIA RTX ray tracing is reinventing computer graphics, driving powerful adoption across gaming, VR and design markets, while opening new opportunities in rendering and cloud gaming. NVIDIA AI is enabling breakthroughs in language understanding, conversational AI and recommendation engines ― the core algorithms that power the internet today. And new NVIDIA computing applications in 5G, genomics, robotics and autonomous vehicles enable us to continue important work that has great impact.

“We are well positioned for the greatest technology trends of our time,” he said.

NVIDIA will pay its next quarterly cash dividend of $0.16 per share on March 20, 2020, to all shareholders of record on Feb. 28, 2020.  

Q4 Fiscal 2020 Summary

GAAP
($ in millions, except earnings per share)Q4 FY20Q3 FY20Q4 FY19Q/QY/Y
Revenue$3,105$3,014$2,205Up 3%Up 41%
Gross margin64.9%63.6%54.7%Up 130 bpsUp 1,020 bps
Operating expenses$1,025$989$913Up 4%Up 12%
Operating income$990$927$294Up 7%Up 237%
Net income$950$899$567Up 6%Up 68%
Diluted earnings per share$1.53$1.45$0.92Up 6%Up 66%



Non-GAAP
($ in millions, except earnings per share)Q4 FY20Q3 FY20Q4 FY19Q/QY/Y
Revenue$3,105$3,014$2,205Up 3%Up 41%
Gross margin65.4%64.1%56.0%Up 130 bpsUp 940 bps
Operating expenses$810$774$755Up 5%Up 7%
Operating income$1,220$1,156$479Up 6%Up 155%
Net income$1,172$1,103$496Up 6%Up 136%
Diluted earnings per share$1.89$1.78$0.80Up 6%Up 136%

Fiscal 2020 Summary

GAAP
($ in millions except earnings per share)FY20FY19Y/Y
Revenue$10,918$11,716Down 7%
Gross margin62.0%61.2%Up 80 bps
Operating expenses$3,922$3,367Up 16%
Operating income$2,846$3,804Down 25%
Net income$2,796$4,141Down 32%
Diluted earnings per share$4.52$6.63Down 32%



Non-GAAP
($ in millions except earnings per share)FY20FY19Y/Y
Revenue$10,918$11,716Down 7%
Gross margin62.5%61.7%Up 80 bps
Operating expenses$3,086$2,826Up 9%
Operating income$3,735$4,407Down 15%
Net income$3,580$4,143Down 14%
Diluted earnings per share$5.79$6.64Down 13%

NVIDIA’s outlook for the first quarter of fiscal 2021 does not include any contribution from the pending acquisition of Mellanox Technologies, Ltd. Discussions with China’s regulatory agency, the State Administration for Market Regulation, are progressing, and NVIDIA believes the acquisition will likely close in the early part of calendar 2020.

While the ultimate effect of the coronavirus is difficult to estimate, the company has reduced its revenue outlook for the first quarter of fiscal 2021 by $100 million to account for its potential impact.

  • Revenue is expected to be $3.00 billion, plus or minus 2 percent.
  • GAAP and non-GAAP gross margins are expected to be 65.0 percent and 65.4 percent, respectively, plus or minus 50 basis points.
  • GAAP and non-GAAP operating expenses are expected to be approximately $1.05 billion and $835 million, respectively.
  • GAAP and non-GAAP other income and expense are both expected to be income of approximately $25 million.
  • GAAP and non-GAAP tax rates are both expected to be 9 percent, plus or minus 1 percent, excluding any discrete items. GAAP discrete items include excess tax benefits or deficiencies related to stock-based compensation, which are expected to generate variability on a quarter by quarter basis.

Highlights

Since the end of the third quarter of fiscal 2020, NVIDIA has achieved progress in these areas:

  

Gaming

  • Grew momentum for ray tracing with the launch of such RTX-enabled games as , and .
  • Brought its cloud gaming service out of beta, opening up PC gaming to hundreds of millions of consumers who can now add a virtual GeForce® graphics card to their device and play games they own, as well as free-to-play games.
  • Brought its number of gaming laptops to a record 125 models, including the world’s first , the ASUS ROG Zephyrus G14.
  • at CES, with the launch of the ASUS ROG Swift 360, the world’s fastest monitor, with a 360Hz refresh rate; and with LG adopting G-SYNC in its new lineup of OLED TVs.

Data Center and Edge Computing

  • Unveiled the first scalable GPU-accelerated , with access to up to 800 .
  • Announced that it is powering the HPC5, which has 7,280 NVIDIA V100 GPUs and is operated by Italian energy company Eni.
  • Announced that run on NVIDIA AI, boosting inference by orders of magnitude beyond CPUs.
  • Joined forces with AWS, using NVIDIA T4 Tensor Core GPUs to , bringing Amazon EC2 G4 instances to customers’ data centers.
  • Collaborated with Arm, Ampere Computing, Fujitsu and Marvell on a for , and with Red Hat to bring GPU acceleration to Arm for HPC applications.
  • Introduced , an inference software development kit, paving the way to .
  • Unveiled , a reference application that preserves patient privacy while improving global model accuracy, already in use by the American College of Radiology and UCLA Health.
  • Introduced , a software suite for data scientists and high performance computing researchers that is optimized to eliminate storage and input/output bottlenecks.
  • Released a of the , a unified robotic development platform to accelerate the development and testing of robots.

Professional Visualization

  • Brought from Acer and joined forces with Adobe to provide a complimentary three-month Adobe Creative Cloud membership with new RTX Studio purchases.
  • Introduced , Dassault’s Catia 2020 and Siemens Ray-Trace Studio with the release of a new and .
  • Expanded the reach of into , enabling designers to create complex 3D visuals, accurate reflections and more.

Automotive

  • ™, an advanced software-defined platform for autonomous vehicles capable of achieving 200 TOPS, nearly 7x that of the previous generation SoC.

CFO Commentary

Commentary on the quarter by Colette Kress, NVIDIA’s executive vice president and chief financial officer, is available at .

Conference Call and Webcast Information

NVIDIA will conduct a conference call with analysts and investors to discuss its fourth quarter and fiscal 2020 financial results and current financial prospects today at 2:30 p.m. Pacific time (5:30 p.m. Eastern time). A live webcast (listen-only mode) of the conference call will be accessible at NVIDIA’s investor relations website, . The webcast will be recorded and available for replay until NVIDIA’s conference call to discuss its financial results for its first quarter of fiscal 2021.

Non-GAAP Measures

To supplement NVIDIA’s condensed consolidated financial statements presented in accordance with GAAP, the company uses non-GAAP measures of certain components of financial performance. These non-GAAP measures include non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP income from operations, non-GAAP other income, non-GAAP income tax expense, non-GAAP net income, non-GAAP net income, or earnings, per diluted share, non-GAAP diluted shares, and free cash flow. In order for NVIDIA’s investors to be better able to compare its current results with those of previous periods, the company has shown a reconciliation of GAAP to non-GAAP financial measures. These reconciliations adjust the related GAAP financial measures to exclude stock-based compensation expense, legal settlement costs, acquisition-related and other costs, gains and losses from non-affiliated investments, interest expense related to amortization of debt discount, and the associated tax impact of these items, where applicable. Free cash flow is calculated as GAAP net cash provided by operating activities less purchase of property and equipment and intangible assets. NVIDIA believes the presentation of its non-GAAP financial measures enhances the user’s overall understanding of the company’s historical financial performance. The presentation of the company’s non-GAAP financial measures is not meant to be considered in isolation or as a substitute for the company’s financial results prepared in accordance with GAAP, and the company’s non-GAAP measures may be different from non-GAAP measures used by other companies.





 

NVIDIA CORPORATION
 CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In millions, except per share data)
(Unaudited)
        
        
 Three Months Ended Twelve Months Ended
 January 26, January 27, January 26, January 27,
  2020   2019   2020   2019 
        
Revenue$3,105  $2,205  $10,918  $11,716 
Cost of revenue 1,090   998   4,150   4,545 
Gross profit 2,015   1,207   6,768   7,171 
Operating expenses       
Research and development 738   647   2,829   2,376 
Sales, general and administrative 287   266   1,093   991 
Total operating expenses 1,025   913   3,922   3,367 
Income from operations 990   294   2,846   3,804 
Interest income 41   42   178   136 
Interest expense (12)  (14)  (52)  (58)
Other, net (3)  2   (2)  14 
Total other income 26   30   124   92 
Income before income tax 1,016   324   2,970   3,896 
Income tax expense (benefit) 66   (243)  174   (245)
Net income$950  $567  $2,796  $4,141 
        
Net income per share:       
Basic$1.55  $0.93  $4.59  $6.81 
Diluted$1.53  $0.92  $4.52  $6.63 
        
Weighted average shares used in per share computation:      
Basic 612   609   609   608 
Diluted 621   619   618   625 
        





NVIDIA CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In millions)
(Unaudited)
    
    
 January 26, January 27,
 2020 2019
ASSETS   
    
Current assets:   
Cash, cash equivalents and marketable securities$10,897 $7,422
Accounts receivable, net 1,657  1,424
Inventories 979  1,575
Prepaid expenses and other current assets 157  136
Total current assets 13,690  10,557
    
Property and equipment, net 1,674  1,404
Operating lease assets 618  -
Goodwill 618  618
Intangible assets, net 49  45
Deferred income tax assets 548  560
Other assets 118  108
Total assets$17,315 $13,292
    
LIABILITIES AND SHAREHOLDERS' EQUITY
    
Current liabilities:   
Accounts payable$687 $511
Accrued and other current liabilities 1,097  818
Total current liabilities 1,784  1,329
    
Long-term debt 1,991  1,988
Long-term operating lease liabilities 561  -
Other long-term liabilities 775  633
Total liabilities 5,111  3,950
    
Shareholders' equity 12,204  9,342
Total liabilities and shareholders' equity$17,315 $13,292
    





NVIDIA CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
(Unaudited)
        
        
 Three Months Ended Twelve Months Ended
 January 26, January 27, January 26, January 27,
 2020 2019 2020 2019
        
Cash flows from operating activities:       
Net income$950  $567  $2,796  $4,141 
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation expense 220   156   844   557 
Depreciation and amortization 106   78   381   262 
Deferred income taxes 23   (345)  18   (315)
Other -   (10)  5   (45)
Changes in operating assets and liabilities:       
Accounts receivable (202)  794   (233)  (149)
Inventories 66   (156)  597   (776)
Prepaid expenses and other assets 22   13   77   (55)
Accounts payable 104   (359)  194   (135)
Accrued and other current liabilities 157   109   54   256 
Other long-term liabilities 19   51   28   2 
Net cash provided by operating activities 1,465   898   4,761   3,743 
Cash flows from investing activities:       
Proceeds from maturities of marketable securities -   964   4,744   7,232 
Proceeds from sales of marketable securities 2   314   3,365   428 
Purchases of marketable securities -   (1,036)  (1,461)  (11,148)
Purchases of property and equipment and intangible assets (144)  (203)  (489)  (600)
Investments and other, net (9)  -   (14)  (9)
Net cash provided by (used in) investing activities (151)  39   6,145   (4,097)
Cash flows from financing activities:       
Payments related to repurchases of common stock -   (724)  -   (1,579)
Repayment of Convertible Notes -   (3)  -   (16)
Dividends paid (98)  (98)  (390)  (371)
Proceeds related to employee stock plans 2   3   149   137 
Payments related to tax on restricted stock units (87)  (50)  (551)  (1,032)
Other -   (4)  -   (5)
Net cash used in financing activities (183)  (876)  (792)  (2,866)
Change in cash and cash equivalents 1,131   61   10,114   (3,220)
Cash and cash equivalents at beginning of period 9,765   721   782   4,002 
Cash and cash equivalents at end of period$10,896  $782  $10,896  $782 
         





NVIDIA CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(In millions, except per share data)
(Unaudited)
        
 Three Months Ended  Twelve Months Ended
 January 26,October 27,January 27,January 26,January 27,
 2020 2019 2019 2020  2019
          
GAAP gross profit$2,015  $1,916  $1,207  $6,768  $7,171 
GAAP gross margin 64.9%  63.6%  54.7%  62.0%  61.2%
Stock-based compensation expense (A) 12   15   6   39   27 
Legal settlement costs 3   -   21   14   35 
Non-GAAP gross profit$2,030  $1,931  $1,234  $6,821  $7,233 
Non-GAAP gross margin 65.4%  64.1%  56.0%  62.5%  61.7%
          
GAAP operating expenses$1,025  $989  $913  $3,922  $3,367 
Stock-based compensation expense (A) (208)  (208)  (150)  (805)  (530)
Acquisition-related and other costs (7)  (7)  (1)  (30)  (2)
Legal settlement costs -   -   (7)  (1)  (9)
Non-GAAP operating expenses$810  $774  $755  $3,086  $2,826 
          
GAAP income from operations$990  $927  $294  $2,846  $3,804 
Total impact of non-GAAP adjustments to income from operations 230   229   185   889   603 
Non-GAAP income from operations$1,220  $1,156  $479  $3,735  $4,407 
          
GAAP other income$26  $32  $30  $124  $92 
Losses (Gains) from non-affiliated investments -   -   (1)  1   (12)
Interest expense related to amortization of debt discount -   1   -   2   2 
Non-GAAP other income$26  $33  $29  $127  $82 
          
GAAP net income$950  $899  $567  $2,796  $4,141 
Total pre-tax impact of non-GAAP adjustments 230   230   184   890   593 
Income tax impact of non-GAAP adjustments (B) (8)  (26)  (25)  (106)  (223)
Tax benefit from income tax reform -   -   (230)  -   (368)
Non-GAAP net income$1,172  $1,103  $496  $3,580  $4,143 
          
Diluted net income per share         
GAAP$1.53  $1.45  $0.92  $4.52  $6.63 
Non-GAAP$1.89  $1.78  $0.80  $5.79  $6.64 
          
Weighted average shares used in diluted net income per share computation         
GAAP 621   618   619   618   625 
Anti-dilution impact from note hedge -   -   -   -   (1)
Non-GAAP 621   618   619   618   624 
 
GAAP net cash provided by operating activities$1,465  $1,640  $898  $4,761  $3,743 
Purchase of property and equipment and intangible assets (144)  (104)  (203)  (489)  (600)
Free cash flow$1,321  $1,536  $695  $4,272  $3,143 
          
 
          
(A) Stock-based compensation consists of the following:Three Months Ended Twelve Months Ended
 January 26,October 27,January 27,January 26,January 27,
 2020 2019 2019 2020 2019
Cost of revenue$12  $15  $6  $39  $27 
Research and development$140  $141  $99  $540  $336 
Sales, general and administrative$68  $67  $51  $265  $194 
(B) Income tax impact of non-GAAP adjustments, including the recognition of excess tax benefits or deficiencies related to stock-based compensation under GAAP accounting standard (ASU 2016-09).





NVIDIA CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP OUTLOOK
  
 
 Q1 FY2021 Outlook
  
GAAP gross margin 65.0%
Impact of stock-based compensation expense 0.4%
Non-GAAP gross margin 65.4%
  
 Q1 FY2021 Outlook
 (In millions)
  
GAAP operating expenses$1,045 
Stock-based compensation expense, acquisition-related costs, and other costs (210)
Non-GAAP operating expenses$835 
  

About NVIDIA

NVIDIA’s (NASDAQ: NVDA) invention of the GPU in 1999 sparked the growth of the PC gaming market, redefined modern computer graphics and revolutionized parallel computing. More recently, GPU deep learning ignited modern AI ― the next era of computing ― with the GPU acting as the brain of computers, robots and self-driving cars that can perceive and understand the world. More information at . 

For further information, contact:

Simona Jankowski Robert Sherbin
Investor Relations Corporate Communications
NVIDIA Corporation NVIDIA Corporation
 

Certain statements in this press release including, but not limited to, statements as to: our initiatives achieving great success; the impacts of NVIDIA RTX ray tracing, NVIDIA AI and new NVIDIA computing applications in 5G, genomics, robotics, and autonomous vehicles; NVIDIA’s positioning for the greatest technology trends of our time; NVIDIA’s next quarterly cash dividend; the status of the China regulatory approval process and the expected timing of closing of the Mellanox acquisition; the ultimate effect of the coronavirus; NVIDIA’s financial outlook for the first quarter of fiscal 2021; NVIDIA’s expected tax rates for the first quarter of fiscal 2021; NVIDIA’s expectation to generate variability from excess tax benefits or deficiencies; and the benefits and impact of: GeForce NOW, Alibaba’s and Baidu’s recommendation engines running on NVIDIA AI, NVIDIA TensorRT7, NVIDIA Clara Federated Learning, Magnum IO, the new version of the NVIDIA Isaac software development kit, expanding the reach of RTX technology into Chaos Group’s V-Ray, Autodesk’s Arnold and Blender’s Cycles, and DRIVE AGX Orin are forward-looking statements that are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic conditions; our reliance on third parties to manufacture, assemble, package and test our products; the impact of technological development and competition; development of new products and technologies or enhancements to our existing product and technologies; market acceptance of our products or our partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of our products or technologies when integrated into systems; as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. Copies of reports filed with the SEC are posted on the company’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.

© 2020 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, GeForce, Quadro, DRIVE AGX Orin, GeForce NOW, GeForce RTX, G-SYNC, NVIDIA Clara, NVIDIA Isaac, NVIDIA RTX, and TensorRT are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and/or other countries. Other company and product names may be trademarks of the respective companies with which they are associated. Features, pricing, availability, and specifications are subject to change without notice.

EN
13/02/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NVIDIA Corporation

Wedbush Research
  • Wedbush Research
2454 MEDIATEK INC.
DPZ DOMINO'S PIZZA INC.
SHAK SHAKE SHACK INC. CLASS A
WING WINGSTOP INC.
WEN WENDY'S COMPANY
WDC WESTERN DIGITAL CORPORATION
VLY VALLEY NATIONAL BANCORP
TXRH TEXAS ROADHOUSE INC.
TSCO TRACTOR SUPPLY COMPANY
SKX SKECHERS U.S.A. INC. CLASS A
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SBUX STARBUCKS CORPORATION
PSTG PURE STORAGE INC. CLASS A
PEGA PEGASYSTEMS INC.
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
MTH MERITAGE HOMES CORPORATION
MCD MCDONALD'S CORPORATION
INTC INTEL CORPORATION
IMAX IMAX CORPORATION
GOOGL ALPHABET INC. CLASS A
FFWM FIRST FOUNDATION
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
EWBC EAST WEST BANCORP INC.
EAT BRINKER INTERNATIONAL INC.
DENN DENNY'S CORPORATION
CUBI CUSTOMERS BANCORP INC.
CTMX CYTOMX THERAPEUTICS INC.
COLB COLUMBIA BANKING SYSTEM INC.
CMRX CHIMERIX INC
CHKP CHECK POINT SOFTWARE TECHNOLOGIES LTD.
BPMC BLUEPRINT MEDICINES CORP.
AXTI AXT INC.
BJRI BJ'S RESTAURANTS INC.
CFR CULLEN/FROST BANKERS INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ROKU ROKU INC. CLASS A
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
SRRK SCHOLAR ROCK HOLDING CORPORATION
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
SWTX SPRINGWORKS THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
RVMD IDEAYA BIOSCIENCES
BDTX REVOLUTION MEDICINES
ITOS BLACK DIAMOND THERAPEUTICS
ORIC ITEOS THERAPEUTICS
ZNTL ORIC PHARMACEUTICALS
BEAM ZENTALIS PHARMACEUTICALS
COGT BEAM THERAPEUTICS
IMNM COGENT BIOSCIENCES INC
VOR IMMUNOME
NUVB VOR BIOPHARMA
DAWN NUVATION BIO INC (A)
ELEV DAY ONE BIOPHARMACEUTICALS INC
FHTX ELEVATION ONCOLOGY
STX FOGHORN THERAPEUTICS
IKNA SEAGATE TECHNOLOGY HLDGS PLC
TCRX IKENA ONCOLOGY INC
HOWL TSCAN THERAPEUTICS INC
GLUE WEREWOLF THERAPEUTICS INC
GFS MONTE ROSA THERAPEUTICS INC
CMPX GLOBALFOUNDRIES INC
GMTX COMPASS THERAPEUTICS
JANX GEMINI THERAPEUTICS INC
TYRA JANUX THERAPEUTICS INC
HR TYRA BIOSCIENCES INC
NUVL HEALTHCARE TRUST OF AMERICA INC.
BOLD NUVALENT INC
AUDENTES THERAPEUTICS

ResearchPool Subscriptions

Get the most out of your insights

Get in touch